The number of Americans with type 2 diabetes and/or obesity is rising, and the entry of therapies such as glucagon-like ...

A recent breakthrough in diabetes treatment- a cell therapy that cured a patient's diabetes, eliminating the need for insulin ...

Company expects to report top-line data and complete study results in Q3 2024 TORONTO, ONTARIO, June 13, 2024 (GLOBE NEWSWIRE ...

“The prevalence of type-2 diabetes continues to rise in children and adolescents, yet oral treatment options have remained ...

AstraZeneca’s FARXIGA® (dapagliflozin) has been approved by the US Food and Drug Administration (FDA) to improve glycemic control in pediatric patients with type-2 diabetes (T2D) aged 10 years and ...

The Global Insulin Glargine Market Size was Valued at USD 1.38 Billion in 2023 and the Worldwide Insulin Glargine Market Size is Expected to Reach USD 2.50 Billion by 2033, according to a research ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufact ...

Researchers at the University of British Columbia have developed a needle-free method for people with diabetes to control ...

Discover the groundbreaking patent by Crinetics Pharmaceuticals for a somatostatin modulator, offering a new method to suppress key hormones in humans.

In the ever-evolving landscape of weight management, Strut Health is making significant strides with its innovative GLP-1 ...

( NewsNation) — In a clinical trial, researchers in China say they have successfully treated a patient with late-stage type 2 ...

Maintaining Oral Hygiene Practicing good oral hygiene ... adhering to prescribed medications or insulin regimens, and ...